One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage Plus membership.
Explore Editage Plus
Audio Papers
Ask R Discovery
Translation
Auto-sync
Collaboration
Open Accesshttps://doi.org/10.1182/blood-2020-137020
Copy DOI
Export
Save
Share
Cite Journal: Blood |  Publication Date: Nov 5, 2020 |
Affiliation: Stony Brook University, University Hospitals of Cleveland, Cornell University, Presbyterian Hospital, NewYork–Presbyterian Hospital, New York Hospital Queens, Institut Jules Bordet, Northwestern University, Hospital Universitario Virgen del Rocío, Sorbonne Université, Pitié-Salpêtrière Hospital, Hôpital Lyon Sud, Karyopharm Therapeutics (United States), Oxford University Hospitals NHS Trust, University of Liverpool, Medical University of Vienna, University of Turin, Cleveland Clinic, NIHR CRUK Experimental Cancer Medicine Centre, University of Southampton, Cancer Research UK, King's College Hospital, University of Chicago, Rabin Medical Center, Hackensack University Medical Center, Cliniques Universitaires Saint-Luc, Institute Paoli-Calmettes, Ghent University Hospital, The University of Texas MD Anderson Cancer Center, Hospital Universitario La Paz, Délégation Paris 7, Assistance Publique – Hôpitaux de Paris, Université Paris Cité, Hôpital Saint-Louis, Inserm, Vrije Universiteit Amsterdam, Amsterdam University Medical Centers, Addenbrooke's Hospital, Leiden University Medical Center
Effect of Age on the Efficacy and Safety of Single Agent Oral Selinexor in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL): A Post-Hoc Analysis of the Sadal Pivotal Study
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
